Company Announcement no. 14/2016
To: NASDAQ OMX Copenhagen A/S
Hørsholm, Denmark, 29 June 2016
Veloxis Receives Envarsus XR® Package Insert Label Enhancements Based on Study
of African-American Transplant Recipients
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that once-daily
Envarsus XR® (tacrolimus extended-release tablets), indicated for the
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.